APAC Digital Diabetes Management Market size to cross $12 Bn by 2027

Published Date: 2021-03-04

Request a sample

APAC Digital Diabetes Management Market size projected to reach USD 12 billion by 2027, according to a latest forecast report by Graphical Research.

Increasing geriatric population coupled with rising incidence of diabetes in the region will drive the market growth. Increase in number of obese people and rapid urbanization-associated lifestyle changes are surging the incidence of diabetes. Furthermore, rising healthcare expenditure to diabetes and growing awareness about diabetes preventive care will also boost the market demand.

Technological advancements in the field of connected devices and advent of artificial intelligence & big data are transforming the digital diabetes care sector. Researchers in diabetes space are harnessing patient’s data with help of connected devices. Connecting the data using digital diabetes devices is driving the region at a forefront of research in diabetes space.

Devices segment held the majority digital diabetes management market share during the forecast period owing to high cost of devices and increasing usage. Increasing adoption rate of digital diabetes devices and continuous technological advancements are the factors contributing to the market revenue. In devices segment, smart insulin pen is estimated to progress at 21.3% CAGR between 2021 and 2027. Increasing number of product launches and technological collaboration by smart insulin pen makers with other connected technologies are transforming the market.  

Type 1 diabetes segment is predicted to register a growth of over 19% till 2027. Type 1 diabetes occurs when some or all insulin producing cells in pancreas are destroyed. Hence, type patients are highly dependent on insulin. High adoption rate of insulin delivery devices and connected technologies in type 1 patients are contributing to the segment growth.

Browse detailed statistical insights from the report, “Asia Pacific Digital Diabetes Management Market Size By Patient Type (Type 1, Type 2), By Product Type (Devices {Smart Glucose Meters, CGM, Insulin Pumps & Patches, Insulin Pens}, By Device Type [Wearable, Handheld], Services {Diabetes Apps, Software}), By End-Use (Hospitals, Home Settings, Diagnostic Centers & Clinics), Research Report, Country Outlook (China, Japan, India, Australia, South Korea, Malaysia, Indonesia, Thailand, Singapore, Taiwan, Philippines, Vietnam), Price Trends, Growth Prospects, Competitive Industry Share & Forecasts, 2021 - 2027” along with the table of contents (ToC) @

Hospitals segment is set to observe a 19.3% growth rate through 2027. Increasing use of digital diabetes devices in hospitals and rise in hospital admissions due to various chronic diseases is further contributing to the segment growth. Patients with diabetes have longer hospital stay and higher rate of mortality and complications. Thus, increasing number of hospital admissions and rise in demand for continuous monitoring of blood glucose in hospitals will influence the segment expansion.

India digital diabetes management market is poised to record a CAGR of around 21% during the forecast timeframe. Improving healthcare facilities and rise in expenditure on diabetes are the factors contributing to the market value. Increasing awareness about diabetes and rising government initiatives to curb the burden diabetes are boosting the market growth. Furthermore, presence of large diabetes population and increasing adoption of digital diabetes devices are propelling the market size.

Major players in the market are include Abbott Laboratories, Medtronic Plc, Insulet Corporation, F.Hoffmann-LA Roche Ltd., Dexcom, Inc., Companion Medical, Ypsomed, Tandem Diabetes, and Glooko, Inc, among several others. These market players are undertaking various market strategies initiative such as technological collaboration, product innovation, mergers and acquisition acquisitions to set their footprint in the region. For instance, in May 2019, Roche Diabetes Care India launched Accu-chek Instant and Mysugar app. This is the Integrated Diabetes Management Solution (IDMS) will provide advance connectivity and accuracy to diabetes patients, thereby strengthening customer base.

APAC digital diabetes management market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2016 to 2027, for the following segments:

Asia Pacific Market, By Product Type, 2016-2027 (USD Million)

  • Devices

By device

  • Smart Blood Glucose Meters
  • Smart CGM
  • Smart Insulin Pumps
  • Smart Insulin Pens

By device type

  • Handheld
  • Wearable
  • Services
  • Apps
  • Software

Asia Pacific Market, By Patient Type, 2016-2027 (USD Million)

  • Type 1
  • Type 2

Asia Pacific Market, By End-use, 2016 – 2027 (USD Million)

  • Hospitals
  • Home settings
  • Diagnostics centers & clinics
  • Others

The above information has been provided for the following countries:

  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Malaysia
    • Indonesia
    • Thailand
    • Singapore
    • Taiwan
    • Philippines
    • Vietnam
    • Others